Engineered keratin/bFGF hydrogel to promote diabetic wound healing in rats
Copyright © 2024. Published by Elsevier B.V..
Keratin materials are promising in wound healing acceleration, however, it is a challenge for the keratin to efficiently therapy the impaired wound healing, such as diabetic foot ulcers. Here, we report a keratin/bFGF hydrogel for skin repair of chronic wounds in diabetic rats based on their characteristics of extracellular matrix and growth factor degradation in diabetic ulcer. Recombinant keratin 31 (K31), the most abundant keratin in human hair, exhibited the highly efficient performances in cell adhesion, proliferation and migration. More importantly, the introduction of bFGF into K31 hydrogel significantly enhances the properties of cell proliferation, wound closure acceleration, angiogenesis and skin appendages regeneration. Furthermore, the combination of K31 and bFGF can promote epithelial-mesenchymal transition by inhibiting the expression of E-cadherin and promoting the expression of vimentin and fibronectin. These findings demonstrate the engineered K31/bFGF hydrogel as a promising therapeutic agent for diabetic wound healing.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:261 |
---|---|
Enthalten in: |
International journal of biological macromolecules - 261(2024), Pt 1 vom: 24. März, Seite 129725 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Sun, Changfa [VerfasserIn] |
---|
Links: |
---|
Themen: |
68238-35-7 |
---|
Anmerkungen: |
Date Completed 11.03.2024 Date Revised 11.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.ijbiomac.2024.129725 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM367628295 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM367628295 | ||
003 | DE-627 | ||
005 | 20240311232144.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240126s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ijbiomac.2024.129725 |2 doi | |
028 | 5 | 2 | |a pubmed24n1323.xml |
035 | |a (DE-627)NLM367628295 | ||
035 | |a (NLM)38272410 | ||
035 | |a (PII)S0141-8130(24)00528-2 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Sun, Changfa |e verfasserin |4 aut | |
245 | 1 | 0 | |a Engineered keratin/bFGF hydrogel to promote diabetic wound healing in rats |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 11.03.2024 | ||
500 | |a Date Revised 11.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2024. Published by Elsevier B.V. | ||
520 | |a Keratin materials are promising in wound healing acceleration, however, it is a challenge for the keratin to efficiently therapy the impaired wound healing, such as diabetic foot ulcers. Here, we report a keratin/bFGF hydrogel for skin repair of chronic wounds in diabetic rats based on their characteristics of extracellular matrix and growth factor degradation in diabetic ulcer. Recombinant keratin 31 (K31), the most abundant keratin in human hair, exhibited the highly efficient performances in cell adhesion, proliferation and migration. More importantly, the introduction of bFGF into K31 hydrogel significantly enhances the properties of cell proliferation, wound closure acceleration, angiogenesis and skin appendages regeneration. Furthermore, the combination of K31 and bFGF can promote epithelial-mesenchymal transition by inhibiting the expression of E-cadherin and promoting the expression of vimentin and fibronectin. These findings demonstrate the engineered K31/bFGF hydrogel as a promising therapeutic agent for diabetic wound healing | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Diabetic foot ulcer | |
650 | 4 | |a Hydrogel dressing | |
650 | 4 | |a Keratin 31 | |
650 | 4 | |a Tissue repair | |
650 | 4 | |a bFGF | |
650 | 7 | |a Hydrogels |2 NLM | |
650 | 7 | |a Keratins |2 NLM | |
650 | 7 | |a 68238-35-7 |2 NLM | |
700 | 1 | |a Huang, Yuqian |e verfasserin |4 aut | |
700 | 1 | |a Wang, Lili |e verfasserin |4 aut | |
700 | 1 | |a Deng, Jia |e verfasserin |4 aut | |
700 | 1 | |a Qing, Rui |e verfasserin |4 aut | |
700 | 1 | |a Ge, Xin |e verfasserin |4 aut | |
700 | 1 | |a Han, Xue |e verfasserin |4 aut | |
700 | 1 | |a Zha, Guodong |e verfasserin |4 aut | |
700 | 1 | |a Pu, Wei |e verfasserin |4 aut | |
700 | 1 | |a Wang, Bochu |e verfasserin |4 aut | |
700 | 1 | |a Hao, Shilei |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t International journal of biological macromolecules |d 1992 |g 261(2024), Pt 1 vom: 24. März, Seite 129725 |w (DE-627)NLM012627356 |x 1879-0003 |7 nnns |
773 | 1 | 8 | |g volume:261 |g year:2024 |g number:Pt 1 |g day:24 |g month:03 |g pages:129725 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ijbiomac.2024.129725 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 261 |j 2024 |e Pt 1 |b 24 |c 03 |h 129725 |